Acceptability of self-sample human papillomavirus testing among transmasculine people

• Conditions: human papillomavirus infection; transgender men; human papilloma virus; HPV

• Registration Number: TCTR20240427010
• Lead Sponsor: Ratchadapisek Research Funds

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-27
• Last Update Posted: 19 August 2024
• Study Completion: 2025-05-01

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 295

Inclusion Criteria

Transmasculine diagnosed with gender dysphoria (based on DSM-5)
Ages 25-65 years old visiting at Gender Health Clinic
Willing and able to provide informed consent.
Willing to provide information
Fluent in Thai language

Exclusion Criteria

Abnormal uterine or vaginal bleeding
History or current abnormal cervical cytology
Has undergone metoidioplasty
Has undergone hysterectomy
Pregnancy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the acceptability of self-collected high risk HPV testing among transgender men at time visiting OPD questionnaire

Secondary Outcome Measures

Name	Time	Method
To evaluate the barriers to healthcare screening systems among transgender men at time visiting OPD Questionnaire,o compare the acceptability of self and provider-collected high risk HPV testing at time visiting OPD Questionaire